Here, we demonstrate that Angptl2 deficiency in tumor cells enhances the activation of CD8+ T cells in kidney tissues and slows tumor progression in a tRCC mouse model. Here, CD8A is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.